Home
About
Services
Partners
Client Portfolio
News
Contact
U.S. regulator to review recommendation on Fiat Chrysler’s Jeep complaint against Mahindra
January 23, 2020
U.S. regulator plans enforcement actions against former Wells Fargo executives: source
January 23, 2020
0
Blues health insurers put up $55 million to take on generic drug makers
Published by
Muller&Green
at
January 23, 2020
Categories
RSS
Tags
A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper prices to their members on generic drugs that currently have little or no competition, the companies said on Thursday.
Powered by
WPeMatico
Muller&Green
Related posts
December 17, 2024
Five Lessons From My Mentor
Read more
December 13, 2024
Where Does Corporate Climate Action Go Next?
Read more
December 12, 2024
CEO of the Year Lisa Su Talks Competition and Collaboration in the Semiconductor Industry
Read more